BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Boston - ECPv6.17.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://scienceinboston.com
X-WR-CALDESC:Events for Science in Boston
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20210917T123000
DTEND;TZID=America/Toronto:20210917T140000
DTSTAMP:20210817T203855Z
CREATED:20210817T203855Z
LAST-MODIFIED:20210817T203855Z
UID:16037-1631881800-1631887200@scienceinboston.com
SUMMARY:Modifying Humans: Is Global Governance of Genome Editing Possible?
DESCRIPTION:Join us online for the September Ethics in Research and Biotechnology Consortium. In this interactive session\, Dr. Robin Lovell-Badge and Dr. Insoo Hyun will lead the audience through a discussion of the scientific\, ethical\, and policy considerations raised by efforts to successfully implement oversight and governance of genome editing
URL:https://scienceinboston.com/event/modifying-humans-is-global-governance-of-genome-editing-possible/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20210917T123000
DTEND;TZID=America/Toronto:20210917T140000
DTSTAMP:20210817T203855Z
CREATED:20210817T203855Z
LAST-MODIFIED:20210817T203855Z
UID:27742-1631881800-1631887200@scienceinboston.com
SUMMARY:Modifying Humans: Is Global Governance of Genome Editing Possible?
DESCRIPTION:Join us online for the September Ethics in Research and Biotechnology Consortium. In this interactive session\, Dr. Robin Lovell-Badge and Dr. Insoo Hyun will lead the audience through a discussion of the scientific\, ethical\, and policy considerations raised by efforts to successfully implement oversight and governance of genome editing
URL:https://scienceinboston.com/event/modifying-humans-is-global-governance-of-genome-editing-possible-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20210923T160000
DTEND;TZID=America/Toronto:20210923T170000
DTSTAMP:20210913T175052Z
CREATED:20210913T164148Z
LAST-MODIFIED:20210913T175052Z
UID:16408-1632412800-1632416400@scienceinboston.com
SUMMARY:Colloquium on the Brain and Cognition with Dr. Michelle Monje\, Stanford University
DESCRIPTION:Michelle Monje\, MD\, PhD\, is an associate professor of Neurology and Neurological Sciences at Stanford University. She received her M.D. and Ph.D. in Neuroscience from Stanford and completed her residency training in neurology at the Massachusetts General Hospital/Brigham and Women’s Hospital/Harvard Medical School Partners program\, and then returned to Stanford for a clinical fellowship in pediatric neuro-oncology and postdoctoral fellowship in developmental and cancer biology. Dr. Monje is recognized as an international leader in the pathophysiology of glioma\, especially diffuse intrinsic pontine glioma (DIPG)/H3K27M-mutated diffuse midline gliomas and a pioneer in the emerging field of Cancer Neuroscience. Her clinical focus is on childhood glial malignancies and cognitive impairment after childhood cancer therapy. Her laboratory studies neuron-glial interactions in health and disease\, with a particular focus on mechanisms and consequences of neuron-glial interactions in health\, glial dysfunction in cancer therapy-related cognitive impairment and neuron-glial interactions in malignant glioma. Together with these basic studies\, her research program has advanced preclinical studies of novel therapeutics for pediatric high-grade gliomas and cancer therapy-related cognitive impairment in order to translate new therapies to the clinic. She has led several of her discoveries from basic molecular work to clinical trials for children and young adults with brain tumors. \nThis event is being held virtually. Please click here to attend. \nHost: Li-Huei Tsai\nOrganizer: Brittany Greenough\nZoom: https://mit.zoom.us/j/99545907722
URL:https://scienceinboston.com/event/colloquium-on-the-brain-and-cognition-with-dr-michelle-monje-stanford-university/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20210923T160000
DTEND;TZID=America/Toronto:20210923T170000
DTSTAMP:20210913T164148Z
CREATED:20210913T164148Z
LAST-MODIFIED:20210913T164148Z
UID:27746-1632412800-1632416400@scienceinboston.com
SUMMARY:Colloquium on the Brain and Cognition with Dr. Michelle Monje\, Stanford University
DESCRIPTION:Michelle Monje\, MD\, PhD\, is an associate professor of Neurology and Neurological Sciences at Stanford University. She received her M.D. and Ph.D. in Neuroscience from Stanford and completed her residency training in neurology at the Massachusetts General Hospital/Brigham and Women’s Hospital/Harvard Medical School Partners program\, and then returned to Stanford for a clinical fellowship in pediatric neuro-oncology and postdoctoral fellowship in developmental and cancer biology. Dr. Monje is recognized as an international leader in the pathophysiology of glioma\, especially diffuse intrinsic pontine glioma (DIPG)/H3K27M-mutated diffuse midline gliomas and a pioneer in the emerging field of Cancer Neuroscience. Her clinical focus is on childhood glial malignancies and cognitive impairment after childhood cancer therapy. Her laboratory studies neuron-glial interactions in health and disease\, with a particular focus on mechanisms and consequences of neuron-glial interactions in health\, glial dysfunction in cancer therapy-related cognitive impairment and neuron-glial interactions in malignant glioma. Together with these basic studies\, her research program has advanced preclinical studies of novel therapeutics for pediatric high-grade gliomas and cancer therapy-related cognitive impairment in order to translate new therapies to the clinic. She has led several of her discoveries from basic molecular work to clinical trials for children and young adults with brain tumors. \nThis event is being held virtually. Please click here to attend. \nHost: Li-Huei Tsai\nOrganizer: Brittany Greenough\nZoom: https://mit.zoom.us/j/99545907722
URL:https://scienceinboston.com/event/colloquium-on-the-brain-and-cognition-with-dr-michelle-monje-stanford-university-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20210924T160000
DTEND;TZID=America/Toronto:20210924T170000
DTSTAMP:20210920T030507Z
CREATED:20210920T030507Z
LAST-MODIFIED:20210920T030507Z
UID:16508-1632499200-1632502800@scienceinboston.com
SUMMARY:MIT Microbiome Club General Body Meeting with Prof. Alvaro Sanchez
DESCRIPTION:Friday\, September 24th\n4:00 pm ET\nZoom\nPassword: Microbiome \nJoin us for the MIT Microbiome Club‘s first meeting of the year! \nThe first half of the meeting will be dedicated to discussing our club\, talking about what we accomplished last year\, and how you can get involved this year. We’re looking for many new people to join our board and help plan our amazing events! \nDuring the second half of the meeting\, Prof. Alvaro Sanchez\, an Associate Professor of Ecology and Evolutionary Biology at Yale University\, will talk to us about his work on quantitatively predicting microbial evolution\, ecology and behavior​. \nEvent will be virtual and free to the general public. Please RSVP on Eventbrite here​.
URL:https://scienceinboston.com/event/mit-microbiome-club-general-body-meeting-with-prof-alvaro-sanchez/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20210924T160000
DTEND;TZID=America/Toronto:20210924T170000
DTSTAMP:20210920T030507Z
CREATED:20210920T030507Z
LAST-MODIFIED:20210920T030507Z
UID:27748-1632499200-1632502800@scienceinboston.com
SUMMARY:MIT Microbiome Club General Body Meeting with Prof. Alvaro Sanchez
DESCRIPTION:Friday\, September 24th\n4:00 pm ET\nZoom\nPassword: Microbiome \nJoin us for the MIT Microbiome Club‘s first meeting of the year! \nThe first half of the meeting will be dedicated to discussing our club\, talking about what we accomplished last year\, and how you can get involved this year. We’re looking for many new people to join our board and help plan our amazing events! \nDuring the second half of the meeting\, Prof. Alvaro Sanchez\, an Associate Professor of Ecology and Evolutionary Biology at Yale University\, will talk to us about his work on quantitatively predicting microbial evolution\, ecology and behavior​. \nEvent will be virtual and free to the general public. Please RSVP on Eventbrite here​.
URL:https://scienceinboston.com/event/mit-microbiome-club-general-body-meeting-with-prof-alvaro-sanchez-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20210928T084500
DTEND;TZID=America/Toronto:20210928T123000
DTSTAMP:20210920T163544Z
CREATED:20210920T163544Z
LAST-MODIFIED:20210920T163544Z
UID:16564-1632818700-1632832200@scienceinboston.com
SUMMARY:Perturbations\, Therapeutics\, and Machine Learning
DESCRIPTION:The Jameel Clinic and Eric and Wendy Schmidt Center are partnering to organize a workshop on “Perturbations\, Therapeutics\, and Machine Learning”. The workshop will bring together speakers from multiple disciplines that are focused on taking on some of the toughest challenges at the interface of machine learning and biology. With our commitment to community building and open sharing of knowledge\, we would love it if you could join. \nThe workshop will be held on Tuesday\, September 28\, 2021 starting at 8:45 am EDT until 12:30 pm EDT. The workshop is an open event — feel free to invite your colleagues\, collaborators\, students\, and anyone who would benefit from the workshop.
URL:https://scienceinboston.com/event/perturbations-therapeutics-and-machine-learning/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20210928T084500
DTEND;TZID=America/Toronto:20210928T123000
DTSTAMP:20210920T163544Z
CREATED:20210920T163544Z
LAST-MODIFIED:20210920T163544Z
UID:27749-1632818700-1632832200@scienceinboston.com
SUMMARY:Perturbations\, Therapeutics\, and Machine Learning
DESCRIPTION:The Jameel Clinic and Eric and Wendy Schmidt Center are partnering to organize a workshop on “Perturbations\, Therapeutics\, and Machine Learning”. The workshop will bring together speakers from multiple disciplines that are focused on taking on some of the toughest challenges at the interface of machine learning and biology. With our commitment to community building and open sharing of knowledge\, we would love it if you could join. \nThe workshop will be held on Tuesday\, September 28\, 2021 starting at 8:45 am EDT until 12:30 pm EDT. The workshop is an open event — feel free to invite your colleagues\, collaborators\, students\, and anyone who would benefit from the workshop.
URL:https://scienceinboston.com/event/perturbations-therapeutics-and-machine-learning-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20210928T160000
DTEND;TZID=America/Toronto:20210928T170000
DTSTAMP:20210908T230710Z
CREATED:20210908T230710Z
LAST-MODIFIED:20210908T230710Z
UID:16327-1632844800-1632848400@scienceinboston.com
SUMMARY:The Genetics of Opioid Addiction: What We Know\, What We Are Learning
DESCRIPTION:The opioid epidemic is a pressing public health crisis. Opioid overdoses have become the leading cause of accidental death\, surpassing automobile accidents. This crisis has only been exacerbated during the COVID-19 pandemic with overdose deaths spiking up to 25% higher. Genetics is a major contributor to opioid use disorder\, and understanding the genes and gene variations involved could reveal critical aspects of the biology of addiction. \nWhitehead Institute Member Olivia Corradin and her lab are studying the genetics underlying opioid overdose. In this webinar\, she will describe the changes they have identified in the brain and how these changes converge on genes critical to the disorder.
URL:https://scienceinboston.com/event/the-genetics-of-opioid-addiction-what-we-know-what-we-are-learning/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20210928T160000
DTEND;TZID=America/Toronto:20210928T170000
DTSTAMP:20210908T230710Z
CREATED:20210908T230710Z
LAST-MODIFIED:20210908T230710Z
UID:27745-1632844800-1632848400@scienceinboston.com
SUMMARY:The Genetics of Opioid Addiction: What We Know\, What We Are Learning
DESCRIPTION:The opioid epidemic is a pressing public health crisis. Opioid overdoses have become the leading cause of accidental death\, surpassing automobile accidents. This crisis has only been exacerbated during the COVID-19 pandemic with overdose deaths spiking up to 25% higher. Genetics is a major contributor to opioid use disorder\, and understanding the genes and gene variations involved could reveal critical aspects of the biology of addiction. \nWhitehead Institute Member Olivia Corradin and her lab are studying the genetics underlying opioid overdose. In this webinar\, she will describe the changes they have identified in the brain and how these changes converge on genes critical to the disorder.
URL:https://scienceinboston.com/event/the-genetics-of-opioid-addiction-what-we-know-what-we-are-learning-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20210930T160000
DTEND;TZID=America/Toronto:20210930T170000
DTSTAMP:20210913T174626Z
CREATED:20210913T174626Z
LAST-MODIFIED:20210913T174626Z
UID:16414-1633017600-1633021200@scienceinboston.com
SUMMARY:Industry Career Chat with Flare Therapeutics
DESCRIPTION:The Boston Postdoctoral Association’s next Industry Career Chat is happening on September 30\, from 4-5 pm. This is a great opportunity for intimate networking between postdocs steering towards industry positions and scientists/hiring managers at biotech\, pharma and startup companies in Boston and Cambridge. Places are limited to 20 participants.\n\n\n\n\n\n\n\nThey are very excited to be hosting Jenny Mertz\, Ph.D\, Senior Director\, Biology\, and Robert Sims\, Ph.D.\, CSO and co-founder of Flare Therapeutics! \nJenny’s Flare characteristics: Moving programs forward with data-driven decisions and having fun doing it! \nJenny has experience ranging from early target discovery\, to supporting phase 3 clinical development in small molecule oncology therapeutics\, while working in discovery biology and leading translational biology over the past 12+ years. Over this time\, Jenny has moved various projects forward with rigor and objectiveness\, working on cross-functional teams to build strong data packages to give the best chance for success\, from early target discovery to translationally focused efforts. \nRobert’s Flare characteristics: Fostering communication and collaboration while having a blast. \nWith 20+ years of experience in the transcription field\, including 10+ years in the drug discovery of gene control\, Robert is passionate about working with diverse and talented teams to discover and develop novel transcription factor medicines. As a founding scientist of Constellation Pharmaceuticals\, he feels fortunate to have experienced and contributed to nearly all aspects of company creation— from concept to becoming a public company\, with multiple programs in clinical development. While at Constellation\, Robert led the discovery and translational efforts for Pelabresib\, a BET bromodomain inhibitor now in phase 3 clinical development for the treatment of myelofibrosis.
URL:https://scienceinboston.com/event/industry-career-chat-with-flare-therapeutics/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20210930T160000
DTEND;TZID=America/Toronto:20210930T170000
DTSTAMP:20210913T174626Z
CREATED:20210913T174626Z
LAST-MODIFIED:20210913T174626Z
UID:27747-1633017600-1633021200@scienceinboston.com
SUMMARY:Industry Career Chat with Flare Therapeutics
DESCRIPTION:The Boston Postdoctoral Association’s next Industry Career Chat is happening on September 30\, from 4-5 pm. This is a great opportunity for intimate networking between postdocs steering towards industry positions and scientists/hiring managers at biotech\, pharma and startup companies in Boston and Cambridge. Places are limited to 20 participants.\n\n\n\n\n\n\n\nThey are very excited to be hosting Jenny Mertz\, Ph.D\, Senior Director\, Biology\, and Robert Sims\, Ph.D.\, CSO and co-founder of Flare Therapeutics! \nJenny’s Flare characteristics: Moving programs forward with data-driven decisions and having fun doing it! \nJenny has experience ranging from early target discovery\, to supporting phase 3 clinical development in small molecule oncology therapeutics\, while working in discovery biology and leading translational biology over the past 12+ years. Over this time\, Jenny has moved various projects forward with rigor and objectiveness\, working on cross-functional teams to build strong data packages to give the best chance for success\, from early target discovery to translationally focused efforts. \nRobert’s Flare characteristics: Fostering communication and collaboration while having a blast. \nWith 20+ years of experience in the transcription field\, including 10+ years in the drug discovery of gene control\, Robert is passionate about working with diverse and talented teams to discover and develop novel transcription factor medicines. As a founding scientist of Constellation Pharmaceuticals\, he feels fortunate to have experienced and contributed to nearly all aspects of company creation— from concept to becoming a public company\, with multiple programs in clinical development. While at Constellation\, Robert led the discovery and translational efforts for Pelabresib\, a BET bromodomain inhibitor now in phase 3 clinical development for the treatment of myelofibrosis.
URL:https://scienceinboston.com/event/industry-career-chat-with-flare-therapeutics-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20211001T140000
DTEND;TZID=America/Toronto:20211001T170000
DTSTAMP:20210817T201219Z
CREATED:20210817T201219Z
LAST-MODIFIED:20210817T201219Z
UID:16031-1633096800-1633107600@scienceinboston.com
SUMMARY:Finding Funding in the Neurosciences: Meet the McKnight Endowment Fund
DESCRIPTION:The McKnight Endowment Fund for Neuroscience\, in partnership with the Office of Research and Foundation Relations\, will present a workshop to help acquaint researchers at BU with the Fund’s mission\, funding priorities\, programs\, and grant application protocols. \nThe McKnight Endowment Fund for Neuroscience is an independent charitable organization\, established by the McKnight Foundation\, that works to bring science closer to the day when diseases of the brain and behavior can be accurately diagnosed\, prevented\, and treated. The Endowment Fund supports innovative research through three competitive annual awards that seek out investigators whose research shows promise in bringing society closer to preventing\, treating\, and curing many devastating diseases. Research supported by the Fund has furthered understanding of such impairments as Alzheimer’s disease\, Parkinson’s disease\, multiple sclerosis\, spinal cord injuries\, and many others. \n\nRegistration:\nhttps://www.bu.edu/research/featured-events/research-how-to-events/finding-funding-in-the-neurosciences-meet-the-mcknight-endowment-fund/
URL:https://scienceinboston.com/event/finding-funding-in-the-neurosciences-meet-the-mcknight-endowment-fund/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20211001T140000
DTEND;TZID=America/Toronto:20211001T170000
DTSTAMP:20210817T201219Z
CREATED:20210817T201219Z
LAST-MODIFIED:20210817T201219Z
UID:27740-1633096800-1633107600@scienceinboston.com
SUMMARY:Finding Funding in the Neurosciences: Meet the McKnight Endowment Fund
DESCRIPTION:The McKnight Endowment Fund for Neuroscience\, in partnership with the Office of Research and Foundation Relations\, will present a workshop to help acquaint researchers at BU with the Fund’s mission\, funding priorities\, programs\, and grant application protocols. \nThe McKnight Endowment Fund for Neuroscience is an independent charitable organization\, established by the McKnight Foundation\, that works to bring science closer to the day when diseases of the brain and behavior can be accurately diagnosed\, prevented\, and treated. The Endowment Fund supports innovative research through three competitive annual awards that seek out investigators whose research shows promise in bringing society closer to preventing\, treating\, and curing many devastating diseases. Research supported by the Fund has furthered understanding of such impairments as Alzheimer’s disease\, Parkinson’s disease\, multiple sclerosis\, spinal cord injuries\, and many others. \n\nRegistration:\nhttps://www.bu.edu/research/featured-events/research-how-to-events/finding-funding-in-the-neurosciences-meet-the-mcknight-endowment-fund/
URL:https://scienceinboston.com/event/finding-funding-in-the-neurosciences-meet-the-mcknight-endowment-fund-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20211012T060000
DTEND;TZID=America/Toronto:20211012T220000
DTSTAMP:20210908T224825Z
CREATED:20210908T224825Z
LAST-MODIFIED:20210908T224825Z
UID:16324-1634018400-1634076000@scienceinboston.com
SUMMARY:Picower Institute Fall 2021 Symposium | Dendrites: Molecules\, Structure\, and Function
DESCRIPTION:Dendrites play a central role in neuronal computation\, and many complex mechanisms shape their structure\, function\, and connectivity. Dendrites can undergo plastic changes during development and learning\, as well as during neurodevelopmental and neurodegenerative disease. We will discuss how the molecular and electrophysiological properties of dendrites enable them to perform complex computations important for sensory-motor processing and higher cognitive function\, and how these can go awry.
URL:https://scienceinboston.com/event/picower-institute-fall-2021-symposium-dendrites-molecules-structure-and-function/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20211012T060000
DTEND;TZID=America/Toronto:20211012T220000
DTSTAMP:20210908T224825Z
CREATED:20210908T224825Z
LAST-MODIFIED:20210908T224825Z
UID:27744-1634018400-1634076000@scienceinboston.com
SUMMARY:Picower Institute Fall 2021 Symposium | Dendrites: Molecules\, Structure\, and Function
DESCRIPTION:Dendrites play a central role in neuronal computation\, and many complex mechanisms shape their structure\, function\, and connectivity. Dendrites can undergo plastic changes during development and learning\, as well as during neurodevelopmental and neurodegenerative disease. We will discuss how the molecular and electrophysiological properties of dendrites enable them to perform complex computations important for sensory-motor processing and higher cognitive function\, and how these can go awry.
URL:https://scienceinboston.com/event/picower-institute-fall-2021-symposium-dendrites-molecules-structure-and-function-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211014T170000
DTEND;TZID=America/Vancouver:20211014T190000
DTSTAMP:20211004T182144Z
CREATED:20211004T182144Z
LAST-MODIFIED:20211004T182144Z
UID:16763-1634230800-1634238000@scienceinboston.com
SUMMARY:MassBio Oktoberfest
DESCRIPTION:MassBio is excited to be back at in-person networking events again! Come join us for our annual Oktoberfest mixer – grow your network and meet other life science professionals in a fun casual environment. Appetizers and drinks will be served. \nAs we return to in-person events\, MassBio will be taking all appropriate precautions while also closely monitoring the latest public health guidance. Accordingly\, attendees are required to be fully vaccinated. \nRegistration will open on September 13th. \n\nWhen: October 14th\, 2021 from 5 – 7PM\nWhere: Cambridge Tech Square Lawn: Technology Square\, Cambridge\, MA 02139\nWho: This event is free for MassBio members. Pre-registration is required.\n\nSpace is extremely limited. If you register and no longer able to attend\, please cancel your registration so we may open it up to another member. \nInterested in increasing your company’s visibility in the #1 life sciences cluster in the world? Contact Jessica Sousa to sponsor MassBio’s Mixers.
URL:https://scienceinboston.com/event/massbio-oktoberfest/
LOCATION:Cambridge Tech Square Lawn\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211014T170000
DTEND;TZID=America/Vancouver:20211014T190000
DTSTAMP:20211004T182144Z
CREATED:20211004T182144Z
LAST-MODIFIED:20211004T182144Z
UID:27751-1634230800-1634238000@scienceinboston.com
SUMMARY:MassBio Oktoberfest
DESCRIPTION:MassBio is excited to be back at in-person networking events again! Come join us for our annual Oktoberfest mixer – grow your network and meet other life science professionals in a fun casual environment. Appetizers and drinks will be served. \nAs we return to in-person events\, MassBio will be taking all appropriate precautions while also closely monitoring the latest public health guidance. Accordingly\, attendees are required to be fully vaccinated. \nRegistration will open on September 13th. \n\nWhen: October 14th\, 2021 from 5 – 7PM\nWhere: Cambridge Tech Square Lawn: Technology Square\, Cambridge\, MA 02139\nWho: This event is free for MassBio members. Pre-registration is required.\n\nSpace is extremely limited. If you register and no longer able to attend\, please cancel your registration so we may open it up to another member. \nInterested in increasing your company’s visibility in the #1 life sciences cluster in the world? Contact Jessica Sousa to sponsor MassBio’s Mixers.
URL:https://scienceinboston.com/event/massbio-oktoberfest-2/
LOCATION:Cambridge Tech Square Lawn\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211018T080000
DTEND;TZID=America/Vancouver:20211018T180000
DTSTAMP:20211004T182312Z
CREATED:20211004T182312Z
LAST-MODIFIED:20211004T182312Z
UID:16767-1634544000-1634580000@scienceinboston.com
SUMMARY:Sanofi Pharma Day 2021
DESCRIPTION:Accelerate your emerging company or idea at Sanofi’s 2021 Pharma Days on October 18 & 19.\nMassBio’s Pharma Days are unparalleled opportunities for emerging innovators to learn from and connect with world-leading biopharmaceutical companies. \nPlease note that in-person attendees are required to be fully vaccinated to participate in the event. Additionally\, masks will be required in all common areas of the event space except for when eating or drinking; in meeting rooms\, attendees can remove masks if they feel comfortable doing so. \nEngage on October 18 from 8 – 9AM ET | Hear from Sanofi leadership during a fireside chat about how Sanofi is evolving to meet the needs of an ever-changing innovation landscape. \nDiscover on October 18 from 3 – 4PM ET | Join Sanofi’s information session for the latest insights on its R&D strategy and therapeutic focus areas in immunology and inflammation (I&I) and cell and gene therapies. \nConnect on October 18 & 19 | Meet one-on-one with Sanofi representatives to discuss collaboration opportunities. Sanofi’s specific areas of interest are: \n\nCell and gene therapies\, including gene editing and non-viral delivery technologies\nImmunology and inflammation\, with a focus on dermatology\, respiratory\, and gastro-intestinal indications\n\nEligibility Guidelines\nSanofi is open to connecting with groundbreaking innovators across all stages of development that have a strong understanding of their technology’s path to product. Sanofi is particularly interested in tangible assets or disruptive technologies. \nProtection of intellectual property rights (ex. patents\, trademarks\, copyright\, trade secrets\, etc.) of your concept is your responsibility and your responsibility alone. Information you include in your application will be shared with Sanofi representatives. Please note that these representatives did NOT sign Non-Disclosure Agreements (NDAs). Therefore\, you should not include any information in your application that you feel could be harmful to your company should that information be disclosed.
URL:https://scienceinboston.com/event/sanofi-pharma-day-2021/
LOCATION:Hybrid
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211018T080000
DTEND;TZID=America/Vancouver:20211018T180000
DTSTAMP:20211004T182312Z
CREATED:20211004T182312Z
LAST-MODIFIED:20211004T182312Z
UID:27752-1634544000-1634580000@scienceinboston.com
SUMMARY:Sanofi Pharma Day 2021
DESCRIPTION:Accelerate your emerging company or idea at Sanofi’s 2021 Pharma Days on October 18 & 19.\nMassBio’s Pharma Days are unparalleled opportunities for emerging innovators to learn from and connect with world-leading biopharmaceutical companies. \nPlease note that in-person attendees are required to be fully vaccinated to participate in the event. Additionally\, masks will be required in all common areas of the event space except for when eating or drinking; in meeting rooms\, attendees can remove masks if they feel comfortable doing so. \nEngage on October 18 from 8 – 9AM ET | Hear from Sanofi leadership during a fireside chat about how Sanofi is evolving to meet the needs of an ever-changing innovation landscape. \nDiscover on October 18 from 3 – 4PM ET | Join Sanofi’s information session for the latest insights on its R&D strategy and therapeutic focus areas in immunology and inflammation (I&I) and cell and gene therapies. \nConnect on October 18 & 19 | Meet one-on-one with Sanofi representatives to discuss collaboration opportunities. Sanofi’s specific areas of interest are: \n\nCell and gene therapies\, including gene editing and non-viral delivery technologies\nImmunology and inflammation\, with a focus on dermatology\, respiratory\, and gastro-intestinal indications\n\nEligibility Guidelines\nSanofi is open to connecting with groundbreaking innovators across all stages of development that have a strong understanding of their technology’s path to product. Sanofi is particularly interested in tangible assets or disruptive technologies. \nProtection of intellectual property rights (ex. patents\, trademarks\, copyright\, trade secrets\, etc.) of your concept is your responsibility and your responsibility alone. Information you include in your application will be shared with Sanofi representatives. Please note that these representatives did NOT sign Non-Disclosure Agreements (NDAs). Therefore\, you should not include any information in your application that you feel could be harmful to your company should that information be disclosed.
URL:https://scienceinboston.com/event/sanofi-pharma-day-2021-2/
LOCATION:Hybrid
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20211019T190000
DTEND;TZID=America/Toronto:20211019T200000
DTSTAMP:20211018T192642Z
CREATED:20210920T192851Z
LAST-MODIFIED:20211018T192642Z
UID:16577-1634670000-1634673600@scienceinboston.com
SUMMARY:Communicating about Science in a World of Misinformation: A Conversation with Linda Henry and Rick Berke
DESCRIPTION:You are invited to join Ruth Lehmann\, President and Director of the Whitehead Institute\, for a series of virtual dialogues with scientific luminaries from academia and visionary leaders from the biotech industry.\nWhat trends in science and technology excite them the most? Which innovations have the potential to dramatically impact the way we live and work?\nBe a part of the conversation. \nLinda Henry\nCEO\, Boston Globe Media Partners\nLinda Henry is the CEO of Boston Globe Media Partners\, which includes The Boston Globe\, boston.com and STAT News. She co-founded and chaired HUBweek\, a civic collaboration between the Boston Globe\, Harvard University\, Massachusetts General Hospital\, and MIT that explored the future being built at the intersection of art\, science and technology. Linda is also a partner in Fenway Sports Group\, a four-time Emmy-award winning television producer\, the founder of GlobeDocs Film Festival\, and a co-Guinness World Record Holder. \nLinda serves as a director of the Red Sox Foundation\, is a Trustee of the Liverpool Football Club Foundation\, Chair of the Boston Globe Foundation\, and Chair of the John W. Henry Family Foundation. In addition\, she is a founder of the Boston Public Market\, serves on the boards of The Engine at MIT\, The Women’s Foundation of Boston\, The Shorenstein Center\, and the BC CEO Club as well as serving on many advisory boards\, including MassChallenge and Solve @ MIT. \nShe received her Bachelor of Science Degree from Babson College\, her Master’s Degree in Real Estate Development from MIT\, and a Master’s in Public Administration from Harvard Kennedy School. She received an Honorary Doctorate of Laws from Babson College in 2019. \nRick Berke\nCo-Founder & Executive Editor\, STAT\nRick Berke is the co-founder and executive editor of STAT. He moved to Boston in early 2015 as STAT’s Employee #1\, charged with assembling a world-class staff to cover health\, medicine\, and the life sciences. He got his start as a reporter for the Baltimore Evening Sun. From there\, he spent most of his career at the New York Times\, where he was chief political correspondent and covered beats including Congress\, the White House\, and national drug policy. As an editor\, for many years he organized the Times’ daily news coverage as assistant managing editor for news. He was also assistant managing editor for features\, as well as Washington editor\, national editor\, political editor\, and video content editor. Before launching STAT\, he was executive editor of Politico. \nRuth Lehmann\nPresident and Director\, Whitehead Institute\nLehmann earned her undergraduate degree and a PhD in biology with Christiane Nüsslein-Volhard from the University of Tübingen\, in her home country of Germany. She has conducted research at the University of Washington\, the University of Freiburg\, the Max Planck Institute for Developmental Biology\, and the Medical Research Council Laboratory of Molecular Biology in Cambridge\, England. She was a Member of the Whitehead Institute Member and on the faculty of MIT from 1988-1996. She then moved to New York University (NYU)\, where she served in a number of leadership roles specifically as the Laura and Isaac Perlmutter Professor of Cell Biology and director of the Skirball Institute of Biomolecular Medicine (2006-2020) and from 2014-2020 as the Chair of the Department of Cell Biology at NYU’s Grossman School of Medicine. She also became an investigator with the Howard Hughes Medical Institute in 1990 and again in 199. In 2020\, Lehmann took on the role of president and director of the Whitehead Institute. She has received national and international recognition\, including election to the National Academy of Sciences as Foreign Associate in 2005 and election as Associate Member of the European Molecular Biology Organization in 2012. She is currently editor-in-chief of the Annual Review of Cell and Developmental Biology and will serve as president of the American Society for Cell Biology starting in 2021.
URL:https://scienceinboston.com/event/communicating-about-science-in-a-world-of-misinformation-a-conversation-with-linda-henry-and-rick-berke/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20211019T190000
DTEND;TZID=America/Toronto:20211019T200000
DTSTAMP:20210920T192851Z
CREATED:20210920T192851Z
LAST-MODIFIED:20210920T192851Z
UID:27750-1634670000-1634673600@scienceinboston.com
SUMMARY:Communicating about Science in a World of Misinformation: A Conversation with Linda Henry and Rick Berke
DESCRIPTION:You are invited to join Ruth Lehmann\, President and Director of the Whitehead Institute\, for a series of virtual dialogues with scientific luminaries from academia and visionary leaders from the biotech industry.\nWhat trends in science and technology excite them the most? Which innovations have the potential to dramatically impact the way we live and work?\nBe a part of the conversation. \nLinda Henry\nCEO\, Boston Globe Media Partners\nLinda Henry is the CEO of Boston Globe Media Partners\, which includes The Boston Globe\, boston.com and STAT News. She co-founded and chaired HUBweek\, a civic collaboration between the Boston Globe\, Harvard University\, Massachusetts General Hospital\, and MIT that explored the future being built at the intersection of art\, science and technology. Linda is also a partner in Fenway Sports Group\, a four-time Emmy-award winning television producer\, the founder of GlobeDocs Film Festival\, and a co-Guinness World Record Holder. \nLinda serves as a director of the Red Sox Foundation\, is a Trustee of the Liverpool Football Club Foundation\, Chair of the Boston Globe Foundation\, and Chair of the John W. Henry Family Foundation. In addition\, she is a founder of the Boston Public Market\, serves on the boards of The Engine at MIT\, The Women’s Foundation of Boston\, The Shorenstein Center\, and the BC CEO Club as well as serving on many advisory boards\, including MassChallenge and Solve @ MIT. \nShe received her Bachelor of Science Degree from Babson College\, her Master’s Degree in Real Estate Development from MIT\, and a Master’s in Public Administration from Harvard Kennedy School. She received an Honorary Doctorate of Laws from Babson College in 2019. \nRick Berke\nCo-Founder & Executive Editor\, STAT\nRick Berke is the co-founder and executive editor of STAT. He moved to Boston in early 2015 as STAT’s Employee #1\, charged with assembling a world-class staff to cover health\, medicine\, and the life sciences. He got his start as a reporter for the Baltimore Evening Sun. From there\, he spent most of his career at the New York Times\, where he was chief political correspondent and covered beats including Congress\, the White House\, and national drug policy. As an editor\, for many years he organized the Times’ daily news coverage as assistant managing editor for news. He was also assistant managing editor for features\, as well as Washington editor\, national editor\, political editor\, and video content editor. Before launching STAT\, he was executive editor of Politico. \nRuth Lehmann\nPresident and Director\, Whitehead Institute\nLehmann earned her undergraduate degree and a PhD in biology with Christiane Nüsslein-Volhard from the University of Tübingen\, in her home country of Germany. She has conducted research at the University of Washington\, the University of Freiburg\, the Max Planck Institute for Developmental Biology\, and the Medical Research Council Laboratory of Molecular Biology in Cambridge\, England. She was a Member of the Whitehead Institute Member and on the faculty of MIT from 1988-1996. She then moved to New York University (NYU)\, where she served in a number of leadership roles specifically as the Laura and Isaac Perlmutter Professor of Cell Biology and director of the Skirball Institute of Biomolecular Medicine (2006-2020) and from 2014-2020 as the Chair of the Department of Cell Biology at NYU’s Grossman School of Medicine. She also became an investigator with the Howard Hughes Medical Institute in 1990 and again in 199. In 2020\, Lehmann took on the role of president and director of the Whitehead Institute. She has received national and international recognition\, including election to the National Academy of Sciences as Foreign Associate in 2005 and election as Associate Member of the European Molecular Biology Organization in 2012. She is currently editor-in-chief of the Annual Review of Cell and Developmental Biology and will serve as president of the American Society for Cell Biology starting in 2021.
URL:https://scienceinboston.com/event/communicating-about-science-in-a-world-of-misinformation-a-conversation-with-linda-henry-and-rick-berke-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211020T090000
DTEND;TZID=America/Vancouver:20211020T100000
DTSTAMP:20211004T182430Z
CREATED:20211004T182430Z
LAST-MODIFIED:20211004T182430Z
UID:16773-1634720400-1634724000@scienceinboston.com
SUMMARY:Jumpstarting Your Start Up
DESCRIPTION:Join this virtual forum to hear from veterans who can share their secrets of success and pitfalls to avoid when getting your new organization off the ground including: \n\nHow to fundraise\nHow to grow smartly after the initial raise\nSecuring space/real estate\nHiring smartly\n\nMassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations\, such as captioning.
URL:https://scienceinboston.com/event/jumpstarting-your-start-up/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211020T090000
DTEND;TZID=America/Vancouver:20211020T100000
DTSTAMP:20211004T182430Z
CREATED:20211004T182430Z
LAST-MODIFIED:20211004T182430Z
UID:27753-1634720400-1634724000@scienceinboston.com
SUMMARY:Jumpstarting Your Start Up
DESCRIPTION:Join this virtual forum to hear from veterans who can share their secrets of success and pitfalls to avoid when getting your new organization off the ground including: \n\nHow to fundraise\nHow to grow smartly after the initial raise\nSecuring space/real estate\nHiring smartly\n\nMassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations\, such as captioning.
URL:https://scienceinboston.com/event/jumpstarting-your-start-up-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20211025T130000
DTEND;TZID=America/Toronto:20211026T163000
DTSTAMP:20211022T224005Z
CREATED:20211022T224005Z
LAST-MODIFIED:20211022T224005Z
UID:17067-1635166800-1635265800@scienceinboston.com
SUMMARY:SENSE.nano 2021: Enabling clinical research and practice
DESCRIPTION:The 2021 SENSE.nano symposium will focus on human subjects research\, exploring how sensors and sensing systems can enable current medical studies and future clinical practice. SENSE.nano 2021 will also serve to help celebrate the re-opening of the expanded Clinical Research Center (CRC) at MIT. \nBroken into two half-day webinars\, SENSE.nano 2021 will investigate human health through various technologies including motion capture\, physiological monitoring\, and sensing tools for the study of bodily fluids. Over a series of invited technical talks\, panel discussions\, presentations by MIT-launched startups\, and views into MIT research today with current graduate students\, this event will provide needs context and solution perspectives in the domains of sensing for medical engineering and science\, and for the care of humans in their environment. \nThe 2021 SENSE.nano Symposium is sponsored by MIT.nano\, the MIT Clinical Research Center (CRC)\, and the MIT Industrial Liaison Program (ILP).
URL:https://scienceinboston.com/event/sense-nano-2021-enabling-clinical-research-and-practice/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20211025T130000
DTEND;TZID=America/Toronto:20211026T163000
DTSTAMP:20211022T224005Z
CREATED:20211022T224005Z
LAST-MODIFIED:20211022T224005Z
UID:27760-1635166800-1635265800@scienceinboston.com
SUMMARY:SENSE.nano 2021: Enabling clinical research and practice
DESCRIPTION:The 2021 SENSE.nano symposium will focus on human subjects research\, exploring how sensors and sensing systems can enable current medical studies and future clinical practice. SENSE.nano 2021 will also serve to help celebrate the re-opening of the expanded Clinical Research Center (CRC) at MIT. \nBroken into two half-day webinars\, SENSE.nano 2021 will investigate human health through various technologies including motion capture\, physiological monitoring\, and sensing tools for the study of bodily fluids. Over a series of invited technical talks\, panel discussions\, presentations by MIT-launched startups\, and views into MIT research today with current graduate students\, this event will provide needs context and solution perspectives in the domains of sensing for medical engineering and science\, and for the care of humans in their environment. \nThe 2021 SENSE.nano Symposium is sponsored by MIT.nano\, the MIT Clinical Research Center (CRC)\, and the MIT Industrial Liaison Program (ILP).
URL:https://scienceinboston.com/event/sense-nano-2021-enabling-clinical-research-and-practice-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20211026T090000
DTEND;TZID=America/Toronto:20211026T170000
DTSTAMP:20211022T224712Z
CREATED:20211022T224712Z
LAST-MODIFIED:20211022T224712Z
UID:17076-1635238800-1635267600@scienceinboston.com
SUMMARY:14th Annual BIDMC Cancer Center Symposium: Targeted and Immune-Based Therapeutics
DESCRIPTION:Watch presentations from some of the most renowned physicians in the field of cancer research.
URL:https://scienceinboston.com/event/14th-annual-bidmc-cancer-center-symposium-targeted-and-immune-based-therapeutics/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20211026T090000
DTEND;TZID=America/Toronto:20211026T170000
DTSTAMP:20211022T224712Z
CREATED:20211022T224712Z
LAST-MODIFIED:20211022T224712Z
UID:27762-1635238800-1635267600@scienceinboston.com
SUMMARY:14th Annual BIDMC Cancer Center Symposium: Targeted and Immune-Based Therapeutics
DESCRIPTION:Watch presentations from some of the most renowned physicians in the field of cancer research.
URL:https://scienceinboston.com/event/14th-annual-bidmc-cancer-center-symposium-targeted-and-immune-based-therapeutics-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20211026T120000
DTEND;TZID=America/Toronto:20211026T133000
DTSTAMP:20211025T193952Z
CREATED:20211022T235553Z
LAST-MODIFIED:20211025T193952Z
UID:17093-1635249600-1635255000@scienceinboston.com
SUMMARY:A Webinar Series: Ethics and COVID-19 (Vaccine Misinformation)
DESCRIPTION:The George Washington University Milken Institute School of Public Health Office of Research Excellence and Bioethics Interest Group present: A Webinar Series: Ethics and COVID-19. \nPlease join us for our 25th webinar to discuss: Vaccine Misinformation. \nModerator: Paul Ndebele\, PhD Assistant Director\, Office of Research Excellence and Professorial Lecturer\, Department of Global Health\, Milken Institute School of Public Health\, GWU. \nGuest Panelists: Nahid Bhadelia\, M.D.\, MALD Founding Director\, Center for Emerging Infectious Diseases Policy & Research (CEID). Associate Professor\, Section of Infectious Diseases\, Boston University School of Medicine. David A. Broniatowski\, Ph.D.\, FPsyS Associate Professor\, Department of Engineering Management and Systems Engineering\, GWU. \nZoom: https://bit.ly/3tCoouS\nPassword: BIGCOVID19. \nFor any questions\, please email gwsphbig@gwu.edu. For individuals who need assistance\, including closed captioning\, please email 24 hours in advance.
URL:https://scienceinboston.com/event/a-webinar-series-ethics-and-covid-19-vaccine-misinformation/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20211026T120000
DTEND;TZID=America/Toronto:20211026T133000
DTSTAMP:20211022T235553Z
CREATED:20211022T235553Z
LAST-MODIFIED:20211022T235553Z
UID:27767-1635249600-1635255000@scienceinboston.com
SUMMARY:A Webinar Series: Ethics and COVID-19 (Vaccine Misinformation)
DESCRIPTION:The George Washington University Milken Institute School of Public Health Office of Research Excellence and Bioethics Interest Group present: A Webinar Series: Ethics and COVID-19. \nPlease join us for our 25th webinar to discuss: Vaccine Misinformation. \nModerator: Paul Ndebele\, PhD Assistant Director\, Office of Research Excellence and Professorial Lecturer\, Department of Global Health\, Milken Institute School of Public Health\, GWU. \nGuest Panelists: Nahid Bhadelia\, M.D.\, MALD Founding Director\, Center for Emerging Infectious Diseases Policy & Research (CEID). Associate Professor\, Section of Infectious Diseases\, Boston University School of Medicine. David A. Broniatowski\, Ph.D.\, FPsyS Associate Professor\, Department of Engineering Management and Systems Engineering\, GWU. \nZoom: https://bit.ly/3tCoouS\nPassword: BIGCOVID19. \nFor any questions\, please email gwsphbig@gwu.edu. For individuals who need assistance\, including closed captioning\, please email 24 hours in advance.
URL:https://scienceinboston.com/event/a-webinar-series-ethics-and-covid-19-vaccine-misinformation-2/
LOCATION:Online
END:VEVENT
END:VCALENDAR